Literature DB >> 412512

Adenosine deaminase activity in lymphocytes.

J L Sullivan, W R Osborne, R J Wedgewood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 412512

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  21 in total

1.  Elevated adenosine deaminase levels in celiac disease.

Authors:  Basak Cakal; Yavuz Beyazit; Seyfettin Koklu; Erdem Akbal; Ibrahim Biyikoglu; Gulsen Yilmaz
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Therapeutic benefit of pentostatin in severe IL-10-/- colitis.

Authors:  Jeffrey B Brown; Goo Lee; Gery R Grimm; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

3.  Adenosine deaminase activity in relation to the appearance of early and late Epstein-Barr virus antigens induced in lymphoblastoid cells.

Authors:  M Margalith; I Hendler
Journal:  Mol Cell Biochem       Date:  1991-12-11       Impact factor: 3.396

4.  Lymphocyte adenosine deaminase activity in children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Jayant Ghosh; Ziledar Ali; Malay Sen; Rajniti Prasad
Journal:  Pediatr Nephrol       Date:  2005-08-13       Impact factor: 3.714

5.  Adenosine deaminase and nucleoside phosphorylase activities in normal human blood mononuclear cell subpopulations.

Authors:  R P MacDermott; G L Tritsch; J F Formeister
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

Review 6.  Nucleotide-metabolizing enzymes and lymphocyte differentiation.

Authors:  R W Barton; I Goldschneider
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

7.  Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.

Authors:  Mustafa Calis; Filiz Ates; Cevat Yazici; Kader Kose; Mehmet Kirnap; Meltem Demir; Murat Borlu; Cem Evereklioglu
Journal:  Rheumatol Int       Date:  2005-05-03       Impact factor: 2.631

8.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  Immune status with empyema thoracis.

Authors:  O P Mishra; K Varshney; Z Ali; G Nath; V K Pathak; B K Das
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

10.  Canine cyclic hematopoiesis is associated with abnormal purine and pyrimidine metabolism.

Authors:  W R Osborne; W P Hammond; D C Dale
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.